Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Psychiatr Res ; 59: 161-6, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25193460

RESUMO

Improved utilization of continuous or intermittent opioid administration in pain treatment necessitates a comparison of the antinociceptive effect and tolerance of these two treatment methods. More importantly, the effect of treatment method on subsequent opioid consumption has not been directly compared, although it is widely assumed that continuous opioid treatment may produce lower addictive liability relative to intermittent opioid treatment. In this study, we compared the antinociceptive effect and tolerance of morphine in rats that received repeated injection (10 mg/kg twice daily for 7 days) or continuous infusion (20 mg/kg daily for 7 days) subcutaneously and the self-administration of intravenous morphine in these rats after 7 days of withdrawal. Both intermittent and continuous morphine treatment produced antinociceptive tolerance, but the exhibition of tolerance differed. Moreover, intermittent morphine pretreatment facilitated subsequent morphine self-administration, whereas continuous morphine pretreatment produced minimal effects, as shown by comparable levels of active responses and morphine consumption between continuous morphine and saline-treated rats. These results suggest that the administration method of opioid should be selected according to the specific pain situation and that continuous opioid administration or long-acting therapy may be advantageous, producing less influence on drug-taking behavior than intermittent administration of short-acting drugs.


Assuntos
Analgésicos Opioides/administração & dosagem , Morfina/administração & dosagem , Medição da Dor/efeitos dos fármacos , Dor/tratamento farmacológico , Administração Intravenosa , Análise de Variância , Animais , Peso Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Vias de Administração de Medicamentos , Sistemas de Liberação de Medicamentos , Tolerância a Medicamentos , Temperatura Alta/efeitos adversos , Masculino , Dor/etiologia , Ratos , Ratos Sprague-Dawley , Autoadministração , Fatores de Tempo
2.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 33(4): 299-304, 2008 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-18460772

RESUMO

OBJECTIVE: To explore the effect of electroacupuncture on heroin seeking behavior and FosB expression in relevant brain regions. METHODS: Rat model of heroin relapse behaviors was developed with progressive fixed ratio program,and model rats were randomly divided into 3 groups: a restraint group, a needle retention group, and a electroacupuncture group. The heroin seeking behavior was elicited by a small dose of heroin. FosB expression in relevnt brain region was assessed with immunohistochemical technique. RESULTS: Tests on reinstatement of drug seeking behavior induced by heroin priming showed that compared with the restraint group, active pokes in the electroacupuncture group decreased significantly(P<0.05). Compared with the restraint group, the expression of FosB positive nuclei in Acd, Pcg and CeA of rats brain both in the electroacupuncture group and the needle retention group (P<0.05) decreased significantly. In LC, the expression of FosB positive nuclei in the needle retention group decreased significantly compared with the restraint group (P<0.05). CONCLUSION: Continuous acupuncture and needle retention attentuate the reinstatement of heroin-seeking behaviors induced by heroin priming, and the inhibitory effect may be mediated partially by the expression of FosB in relevant regions which are involved in the process of heroin addiction.


Assuntos
Encéfalo/metabolismo , Eletroacupuntura/métodos , Dependência de Heroína/metabolismo , Dependência de Heroína/terapia , Proteínas Proto-Oncogênicas c-fos/biossíntese , Tonsila do Cerebelo/metabolismo , Animais , Comportamento Animal , Dependência de Heroína/psicologia , Masculino , Núcleo Accumbens/metabolismo , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley
3.
Shi Yan Sheng Wu Xue Bao ; 38(3): 211-8, 2005 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-16044914

RESUMO

The antisense approach and immunohistochemistry were used to study the effects of different muscarinic receptor (M) subtypes and glial cell derived neurotrophic factor (GDNF) on the scores of morphine-withdrawal syndrome and the expression of c-Fos in locus coeruleus (LC). Intrathecal injection of M2 receptor antisense oligonucleotides (M2AS-oligo) or GDNF antisense oligonucleotides (GDNFAS-oligo) decreased the scores of morphine withdrawal syndrome. The expression of c-Fos positive neurons in the LC increased in morphine-dependent rats and increased to a greater extent after the injection of naloxone (4mg/kg, ip) in morphine dependent rats. Intrathecal injection of M2AS-oligo or GDNFAS-oligo inhibited the increase of c-Fos expression in LC during morphine withdrawal, but there was no effect in case of M1AS-oligo. The results suggest that M2 receptor of spinal cord mediates the neural activation of LC during morphine withdrawal. And the interaction between neurons and glial cells may be involved in the ascending activation process.


Assuntos
Fator Neurotrófico Derivado de Linhagem de Célula Glial/fisiologia , Morfina/efeitos adversos , Oligonucleotídeos Antissenso/farmacologia , Proteínas Proto-Oncogênicas c-fos/metabolismo , Receptores Muscarínicos/fisiologia , Síndrome de Abstinência a Substâncias/metabolismo , Animais , Expressão Gênica/efeitos dos fármacos , Fator Neurotrófico Derivado de Linhagem de Célula Glial/antagonistas & inibidores , Imuno-Histoquímica , Injeções Espinhais , Masculino , Antagonistas Muscarínicos/administração & dosagem , Antagonistas Muscarínicos/farmacologia , Oligonucleotídeos Antissenso/administração & dosagem , Ratos , Ratos Sprague-Dawley
4.
Yao Xue Xue Bao ; 37(8): 611-5, 2002 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-12567774

RESUMO

AIM: To observe mRNA expression of muscarinic acetylcholine receptors in spinal cord and brainstem in morphine dependent or withdrawal rats. METHODS: The mRNA expression level of m1, m2, m3, m4 and m5 were determined by RT-PCR, the beta-actin mRNA expression was used as internal control. RESULTS: The mRNA level of m1, m2, m3, m4 and m5 in spinal cord and m1 and m2 in brainstem were increased significantly during morphine dependence, and the levels of m1, m2, m3 and m4 in spinal cord and m1 in brainstem were decreased 1 h after the injection of naloxone (4 mg.kg-1, i.p.) in morphine dependent rats. Either scopolamine (0.5 mg.kg-1) or pirenzepine (10 mg.kg-1) was shown to significantly decrease the morphine withdrawal symptoms in rats. The levels of m1, m2, m3 and m5 in spinal cord were increased by pretreatment with pirenzepine and the levels of m2, m3 and m4 in spinal cord were increased by pretreatment with scopolamine. CONCLUSION: The adaptive expression of muscarinic receptors at spinal and supraspinal levels play important role in mediating morphine dependence and withdrawal in rats.


Assuntos
Tronco Encefálico/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Dependência de Morfina/metabolismo , Morfina/toxicidade , Receptores Muscarínicos/biossíntese , Medula Espinal/efeitos dos fármacos , Animais , Tronco Encefálico/metabolismo , Masculino , RNA Mensageiro/biossíntese , RNA Mensageiro/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores Muscarínicos/classificação , Receptores Muscarínicos/genética , Medula Espinal/metabolismo , Síndrome de Abstinência a Substâncias/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA